Berodual® Respimat® - inhaler

DRUG2 trials

Sponsors

Boehringer Ingelheim

Conditions

Pulmonary Disease, Chronic Obstructive

Unknown Phase

Postmarketing Surveillance Study to Assess Handling and Patient Satisfaction on Berodual® Respimat® Solution for Inhalation in Comparison to a Powder Inhaler in Patients With Chronic Obstructive Pulmonary Disease

CompletedNCT02231346

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2005-10-31Updated: 2014-09-04

Postmarketing Surveillance Study to Assess Handling and Patient Satisfaction on Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Pulmonary Disease

CompletedNCT02231320

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2005-12-31Updated: 2014-09-04